VIRGINIA, March 21, 2014 — Fibromyalgia research is now focusing on toxins from the environment, foods and manufacturing as accomplices of central nervous system (CNS) and peripheral nervous system (PNS) damage that wreaks havoc with hormone balance, immunological system (IS), chronic inflammation and disrupted physiological homeostasis.
READ ALSO: Fibromyalgia Part 1: The final frontier
The problem is there seem to be little cooperation from one set of researchers to the next. Additionally, vehement denial of adverse affects from industries and governments have led many to believe toxins as safe. In the chemists mind, the dosage makes the toxin, yet ‘safe toxin’ is as oxymoronic as ‘good poison’.
Historically, many of medicine’s greatest achievements and discoveries are the result of a singular physician/researcher’s efforts after studying an area of interest and thanks to financing by government grants and university research facilities.
Many diseases such as Crohns, Alzheimers, Guillain-Barre and so forth bear the name of the research clinician.
This is where Dr. Ritchie C. Shoemaker comes in; he consulted with EPA’s Kenneth Hundel to set about to discover a connection he had noticed between bio-hazard effected rivers and fish with Pfiesteria. Since biotoxins affect water life, Shoemaker wondered what direct line can be drawn to humans?
In the 15 years since Shoemaker and Hundley made their determinations, the findings have stood the test of time. Their findings posit environmental biotoxins are prominent underlying causation for several syndromes and disease that seem to present ambiguous yet shared symptoms with diagnosis that ranged from psychogenic (from the mind) to what was termed ‘neuralgia.’
‘Neuralgia’ is derived from the Greek ‘neuron’ or nerve and ‘algos’ or pain and for more years than not, assigned by physicians as a diagnosis for chronic pain when a specific diagnosis was undetermined.
More women than men were affected by these types of diagnosis. Opioids, Cymbalta and Neurontin are front line pharmaceuticals for treatment, as they are for fibromyalgia (FMS) and chronic pain syndrome (CPS). Both FMS and CPS share chronic fatigue syndrome (CFS).
Just as interesting is the recent study released from Harvard to Lancet medical is ‘new research’ show biotoxins as damaging to the brains and nervous system of infants. What the article stops short of saying is the biotoxins were around for over half a century or more and the infants from many generations ago were equally affected.
An informal and abridged but effective survey of those in the range of 60 years of age reveals no recollection of childhood peers or school mates that suffered from childhood cancer, peanut allergies, ADHD, minimal autism, no parents complaining of CFS, FMS, SBS, but did hear of mothers diagnosed with neuralgia.
Vaccines of the day did not produce a slew of defective children.
One changs is that poorly controlled and perhaps misunderstood biotoxins and excitotoxins became pervasive in modern society. Where water, land and air were once clean, they are now polluted. Foods that were once wholesome became processed and, for years, had no labeling or testing and minimal FDA oversight.
The quality of air became a daily series of multi-colored alerts, industrial waterway industrial/chemical dumps generated fish with lesions and death and drinking water so loaded with chlorine to kill off bad bacteria it also destroyed good bacteria aka flora that our body needs to eliminate waste.
Now, human waste builds up at the cellular and perhaps the molecular level supporting the late medical researcher and Noble laureate Elie Metchnikoff ‘s assertion; “Death begins in the colon.”
This Month marks the 11th year since award winning writer Patti Schmidt wrote of findings Maryland physician Dr. Ritchie C. Shoemaker and EPA neurotoxicologist H. Kenneth Hundel developed what they termed “neurotoxin mediated illness” which suggested valid explanation for multi-system illnesses such as CFS, CPS, SBS, FMS and Lyme disease.
Shoemaker and Hundel believe victims have biomarkers of neurotoxic illness. Based on this belief, Shoemaker designed effective treatment for many cases.
Writer Schmidt went to see Dr. Shoemaker at his Pocomoke, Maryland office as she suffered from multiple symptoms she wished to have diagnosed and treated. Schmidt was put through a battery of tests beginning with a questionnaire and a draw of 12 vials of blood.
The next articles in the series will address endocrine, hormonal, immunological and inflammation issues and how this information relates to aforementioned syndromes.
A recent interview with Dr. Ritchie C. Shoemaker and this author will be available in upcoming articles.
Paul Mountjoy, PhD, is a Virginia based psychotherapist, nutritionist and researcher.